Pharmabiz

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus

InnoCare receives China NMPA approval to initiate phase II trial of TYK2 inhibitor ICP-488 for cutaneous lupus erythematosus: Beijing Wednesday, December 24, 2025, 18:00 Hrs [IST] ...
Pharmabiz

Australia and Indonesia achieve WHO Listed Authority status in medical products regulation

Australia and Indonesia achieve WHO Listed Authority status in medical products regulation: Geneva Wednesday, December 24, 2025, 17:00 Hrs [IST] The World Health Organization (WHO ...
Pharmabiz

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care

Gastroenterologists debunk common digestion & bowel health myths, urge lifestyle-based care: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:40 Hrs [IST] As World Constipation ...
Pharmabiz

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless

Sharda Hospital lead India’s digital healthcare shift by becoming fully paperless: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:30 Hrs [IST] Sharda Hospital has become ...
Pharmabiz

Care ADHD expands set up its 1st Global Capability Centre in India

Care ADHD expands set up its 1st Global Capability Centre in India: Our Bureau, Bengaluru Wednesday, December 24, 2025, 17:15 Hrs [IST] Care ADHD, one of the United Kingdom’s fa ...
Pharmabiz

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign

Emcure and MS Dhoni reignite India’s weight-loss conversation with ‘Winning Over Obesity’ campaign: Our Bureau, Mumbai Wednesday, December 24, 2025, 17:50 Hrs [IST] Emcure P ...